These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22777155)

  • 21. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
    Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
    Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prednisone Pharmacokinetics During Pregnancy and Lactation.
    Ryu RJ; Easterling TR; Caritis SN; Venkataramanan R; Umans JG; Ahmed MS; Clark S; Kantrowitz-Gordon I; Hays K; Bennett B; Honaker MT; Thummel KE; Shen DD; Hebert MF
    J Clin Pharmacol; 2018 Sep; 58(9):1223-1232. PubMed ID: 29733485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.
    Cooper MS; Rabbitt EH; Goddard PE; Bartlett WA; Hewison M; Stewart PM
    J Bone Miner Res; 2002 Jun; 17(6):979-86. PubMed ID: 12054173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients.
    Press RR; Ploeger BA; den Hartigh J; van der Straaten T; van Pelt J; Danhof M; de Fijter JW; Guchelaar HJ
    Ther Drug Monit; 2009 Apr; 31(2):187-97. PubMed ID: 19258929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A practical limited sampling strategy to predict free prednisolone exposure and glycemia in kidney transplant recipients.
    Yates CJ; Barraclough KA; McWhinney BC; Ungerer JP; Fullinfaw RO; Colman PG; Fourlanos S; Cohney SJ
    Ther Drug Monit; 2014 Feb; 36(1):18-23. PubMed ID: 24335760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection.
    Frey BM; Seeberger M; Frey FJ
    Transplantation; 1985 Mar; 39(3):270-4. PubMed ID: 3883592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic drug monitoring of prednisolone after lung transplantation.
    Morton JM; Williamson S; Kear LM; McWhinney BC; Potter J; Glanville AR
    J Heart Lung Transplant; 2006 May; 25(5):557-63. PubMed ID: 16678035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of prednisolone at steady state in young patients with systemic lupus erythematosus on prednisone therapy: an open-label, single-dose study.
    Sagcal-Gironella AC; Sherwin CM; Tirona RG; Rieder MJ; Brunner HI; Vinks AA
    Clin Ther; 2011 Oct; 33(10):1524-36. PubMed ID: 21982386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flexible limited sampling model for monitoring tacrolimus in stable patients having undergone liver transplantation with samples 4 to 6 hours after dosing is superior to trough concentration.
    Langers P; Press RR; den Hartigh J; Cremers SC; Baranski AG; Lamers CB; Hommes DW; van Hoek B
    Ther Drug Monit; 2008 Aug; 30(4):456-61. PubMed ID: 18641539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients.
    Taylor PJ; Kubler PA; Lynch SV; Allen J; Butler M; Pillans PI
    Ann Pharmacother; 2004 Feb; 38(2):205-8. PubMed ID: 14742751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of intravenous cyclosporine area under the concentration-time curve after allogeneic stem cell transplantation.
    Duncan N; Arrazi J; Nagra S; Cook M; Thomson AH; Craddock C
    Ther Drug Monit; 2010 Jun; 32(3):353-8. PubMed ID: 20224513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients.
    Delaloye JR; Kassir N; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Labbé L; Théorêt Y; Litalien C
    Ther Drug Monit; 2011 Aug; 33(4):380-6. PubMed ID: 21743386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring prednisolone and prednisone in saliva: a population pharmacokinetic approach in healthy volunteers.
    Teeninga N; Guan Z; Freijer J; Ruiter AF; Ackermans MT; Kist-van Holthe JE; van Gelder T; Nauta J
    Ther Drug Monit; 2013 Aug; 35(4):485-92. PubMed ID: 23783167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of prednisolone during administration of sirolimus in patients with renal transplants.
    Jusko WJ; Ferron GM; Mis SM; Kahan BD; Zimmerman JJ
    J Clin Pharmacol; 1996 Dec; 36(12):1100-6. PubMed ID: 9013365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis.
    Morrow SA; Stoian CA; Dmitrovic J; Chan SC; Metz LM
    Neurology; 2004 Sep; 63(6):1079-80. PubMed ID: 15452302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of rofecoxib on prednisolone and prednisone pharmacokinetics in healthy subjects.
    Schwartz JI; Mukhopadhyay S; Porras AG; Viswanathan-Aiyer KJ; Adcock S; Ebel DL; Gertz BJ
    J Clin Pharmacol; 2003 Feb; 43(2):187-92. PubMed ID: 12616672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free prednisolone pharmacokinetics predicted from total concentrations in patients with inflammatory - immunonologic conditions.
    Mangin O; Zheng Y; Bouazza N; Foissac F; Benaboud S; Lui G; Hirt D; Mouthon L; Tréluyer JM; Urien S
    Fundam Clin Pharmacol; 2020 Apr; 34(2):270-278. PubMed ID: 31625621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients.
    Gambertoglio JG; Vincenti F; Feduska NJ; Birnbaum J; Salvatierra O; Amend WJ
    J Clin Endocrinol Metab; 1980 Sep; 51(3):561-5. PubMed ID: 6997330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative serum prednisone and prednisolone concentrations following administration to patients with chronic active liver disease.
    Uribe M; Summerskill WH; Go VL
    Clin Pharmacokinet; 1982; 7(5):452-9. PubMed ID: 7140120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.